Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

1F-LSD

Add links
From Wikipedia, the free encyclopedia
(Redirected from 1-formyl-LSD)
1F-LSD
Clinical data
Other names1-(Furan-2-carbonyl)-LSD; 1-(2-Furoyl)-LSD; SYN-L-005; N,N-Diethyl-1-(furan-2-carbonyl)-6-methyl-9,10-didehydroergoline-8β-carboxamide
Routes of
administration		Oral
Drug classSerotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • (6aR,9R)-N,N-diethyl-4-(furan-2-carbonyl)-7-methyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
PubChem CID
Chemical and physical data
FormulaC25H27N3O3
Molar mass417.509 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C(=O)C5=CC=CO5)C
  • InChI=1S/C25H27N3O3/c1-4-27(5-2)24(29)17-12-19-18-8-6-9-20-23(18)16(13-21(19)26(3)14-17)15-28(20)25(30)22-10-7-11-31-22/h6-12,15,17,21H,4-5,13-14H2,1-3H3/t17-,21-/m1/s1
  • Key:VHDXVHVDSPZVCI-DYESRHJHSA-N

1F-LSD, also known as 1-(furan-2-carbonyl)-LSD, 1-(2-furoyl)-LSD, or SYN-L-005, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2] It is thought to act as a prodrug of LSD.[1][2] The drug interacts with serotonin receptors, including the serotonin 5-HT2A receptor, and produces the head-twitch response in rodents, with about 3-fold lower potency than LSD.[1] It hydrolyzes into LSD in rodents.[1] 1F-LSD was patented in 2024[2] and was first described in the scientific literature in 2025.[1] It has been encountered as a novel designer drug in Germany and Japan.[1]

Use and effects

[edit]

Interactions

[edit]

Chemistry

[edit]

Analogues

[edit]

Analogues of 1F-LSD include 1P-LSD, 1cP-LSD, 1B-LSD, 1S-LSD, and 1T-LSD, among others.

Society and culture

[edit]
[edit]

Canada

[edit]

1F-LSD is not an explicitly nor implicitly controlled substance in Canada as of 2025.[3]

United States

[edit]

1F-LSD is not an explicitly controlled substance in the United States.[4] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

[edit]

References

[edit]
  1. 1 2 3 4 5 6 Brandt SD, Kavanagh PV, Gare S, Elliott SP, Stratford A, Halberstadt AL (August 2025). "Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD)". Drug Test Anal. 17 (8): 1283–1293. doi:10.1002/dta.3829. PMC 12319525. PMID 39624022.
  2. 1 2 3 WO 2024/028495, Stratford A, Williamson JP, "Prodrugs of Substituted Ergolines", published 8 February 2024, assigned to Synex Holdings BV
  3. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. 5 December 2025. Retrieved 20 January 2026.
  4. ↑ Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=1F-LSD&oldid=1365804084"